Aurobindo Pharma has incorporated a wholly owned subsidiary, Engenra Biologics, to expand its contract manufacturing operations. Besides contract manufacturing, the objective is also to expand other pharmaceutical manufacturing operations, Aurobindo Pharma said on Tuesday in a filing. Published – February 24, 2026 11:44 pm IST Share this: Click to share on WhatsApp (Opens in new window) WhatsApp Click to share on Facebook (Opens in new window) Facebook Click to share on Threads (Opens in new window) Threads Click to share on X (Opens in new window) X Click to share on Telegram (Opens in new window) Telegram Click to share on LinkedIn (Opens in new window) LinkedIn Click to share on Pinterest (Opens in new window) Pinterest Click to email a link to a friend (Opens in new window) Email More Click to print (Opens in new window) Print Click to share on Reddit (Opens in new window) Reddit Click to share on Tumblr (Opens in new window) Tumblr Click to share on Pocket (Opens in new window) Pocket Click to share on Mastodon (Opens in new window) Mastodon Click to share on Nextdoor (Opens in new window) Nextdoor Click to share on Bluesky (Opens in new window) Bluesky Like this:Like Loading... Post navigation It’s a difficult thing to know when a player should move on: McLeod Alembic Pharma gets U.S. FDA nod for generic antifungal drug